Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed, replacing Revision: v3.5.0. This appears to be an internal version update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:41.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added revision note v3.5.0 and removed revision note v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:27:58.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the prior revision v3.4.2 is superseded. This appears to be a metadata update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-11T18:49:23.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and deletion of notices about government funding lapse and prior Revision: v3.4.1. These updates are administrative in nature and do not modify study data or core page content.
    Difference
    0.5%
    Check dated 2026-02-11T09:27:05.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added a government funding status banner noting possible delays and open status, and updated the site version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:20:42.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and new footer items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed or altered the previous items/labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:22:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.